|
Volumn 113, Issue 3, 2009, Pages 710-715
|
Adalimumab therapy in patients with active rheumatoid arthritis.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ANTIRHEUMATIC AGENT;
MONOCLONAL ANTIBODY;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
FEMALE;
HOSPITALIZATION;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
QUALITY OF LIFE;
RETROSPECTIVE STUDY;
RHEUMATOID ARTHRITIS;
ROMANIA;
TREATMENT OUTCOME;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
QUALITY OF LIFE;
RETROSPECTIVE STUDIES;
ROMANIA;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 77951955897
PISSN: 03008738
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|